Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease: A noninvasive diagnostic tool?

Inflammatory Bowel Diseases

Volumn 14, Issue 1, 2008, Pages 100-105

  Rizzo, Roberta ^a,b   Melchiorri, Loredana ^a   Simone, Loredana ^a   Stignani, Marina ^a   Marzola, Andrea ^a   Gullini, Sergio ^a   Baricordi, Olavio R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Section of Medical Genetics Department of Experimental and Diagnostic Medicine   (Italy)

Author keywords

Crohn's disease; HLA G; IL 10; Ulcerative colitis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; HLA G ANTIGEN; INTERLEUKIN 10;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; DIAGNOSTIC PROCEDURE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SUPERNATANT; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; COLITIS, ULCERATIVE; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED;

EID: 38849176853     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20281     Document Type: Article

References (41)

1. Karlis J, Pentilla I, Tran TB, et al. Characterization of colonic and mesenteric lymph node dendritic cell subpopulations in a murine adoptive transfer model of inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:834-847.
2. Carosella ED, Moreau P, Aractingi S, et al. HLA-G: a shield against inflammatory aggression. Trends Immunol. 2001;10:553-555.
3. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A. 1992;89:3947-3951.
4. Kirszenbaum M, Moreau P, Gluckman E, et al. An alternative spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A. 1994;91:4209-4213.
5. Fujii T, Ishitani A, Geraghty DE. A soluble form of the HLA-G antigens is encoded by a messenger ribonucleic acid containing intron 4. J Immunol. 1994;153:5516-5524.
6. Crisa L, McMaster MT, Ishii JK, et al. Identification of a thymic epithelial cells subset sharing expression of the class Ib HLA-G molecule with fetal trophoblast. J Exp Med. 1997;186:289-298.
7. Yang Y, Chu W, Geraghty DE, et al. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J Immunol. 1996;156:4224.
8. Moreau P, Cabestre FA, Menier C, et al. IL-10 selectively induces HLA-G in human trophoblast and monocytes. Int Immunol. 1999;5:803-811.
9. Seliger B, Abken H, Ferrone S. HLA-G and MIC expression in tumors and their role in anti-tumor immunity. Trends Immunol. 2003;24:82-87.
10. Ibrahim EC, Guerra N, Lacombe MJ, et al. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Cancer Res. 2001;61:6838-6845.
11. Singer G, Rebmann V, Chen YC, et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res. 2003;9:4460-4464.
12. Rebmann V, Regel J, Stolke D, et al. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol. 2003;13:371-377.
13. Onno M, Pangault C, Le Friec G, et al. Modulation of HLA-G antigen expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol. 2000;164:6426-6434.
14. Lozani JM, Gonzales R, Kindelan JM, et al. Monocytes and T lymphocytes in HIV-1 positive patients express HLA-G molecules. AIDS. 2002;16:347-351.
15. Lila N, Amrein C, Guillemain R, et al. Human leukocyte antigen - G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation. 2002;105:1949-1954.
16. Creput C, Le Friec G, Bahri R, et al. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients. Hum Immunol. 2003;11:1033-1038.
17. Aractingi S, Briand N, Le Danff C, et al. HLA-G and NK receptors are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol. 2001;159:71-77.
18. Khosrotehrani K, Le Danff C, Reynaud-Mendel B, et al. HLA-G expression in atopic dermatitis. J Invest Dermatol. 2001;17:750-752.
19. Fainardi E, Rizzo R, Melchiorri L, et al. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings. J Neuroimmunol. 2003;142:149-158.
20. Rouas-Freiss N, Marchal RE, Kirszenbaum M, et al. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci U S A. 1997;94:5249-5254.
21. Fournel S, Aguerre-Girr M, Hue X, et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol. 2000;164:6100-6104.
22. Bainbridge DR, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4(+) lymphocytes. J Reprod Immunol. 2000;48:17-26.
23. Le Friec G, Laupèze B, Fardel O, et al. Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Hum Immunol. 2003;64:752-776.
24. Ristich V, Liang S, Zhang W, et al. Tolerization of dendritic cells by HLA-G. Eur J Immunol. 2005;35:1133-1142.
25. Senju M, Hulstaert F, Lowder J, et al. Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease. Gut. 1991;32:779-783.
26. de Waal MR, Haanen J, Spits H, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J Exp Med. 1991;174:915-924.
27. Kaser A, Nieuwenhuis EE, Strober W, et al. Natural killer T cells in mucosal homeostasis. Ann N Y Acad Sci. 2004;1029:154-168.
28. Torres MI, Le Discorde M, Lorite P, et al. Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease. Int Immunol. 2004;16:579-583.
29. Gasche C, Bakos S, Dejaco C, et al. IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease. J Clin Immunol. 2000;20:362-370.
30. Moreau P, Faure O, Ibrahim EC, et al. Glucocorticoid hormones up-regulate levels of HLA-G transcripts in trophoblasts. Transplant Proc. 2001;33:2277-2280.
31. Lockhart-Mummery HE, Morson BC. Crohn's disease regional enteritis of the large intestine and its distinction from ulcerative colitis. Gut. 1960;1:87-105.
32. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989;298:82-86.
33. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. BMJ. 1955;2:1041-1048.
34. Rizzo R, Mapp CE, Melchiorri L, et al. Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma. J Allergy Clin Immunol. 2005;115:508-513.
35. Rebmann V, Lemaoult J, Rouas-Freiss N, et al. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004. Hum Immunol. 2005;66:853-863.
36. Anderson DJ. Determination of the lower limit of detection. Clin Chem. 1989;35:2152-2153.
37. Rizzo R, et al. Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? J Reprod Immunol. 2007;74:133-142.
38. Ishizuka K, Sugimura K, Homma T, et al. Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1 beta ratio in the colonic mucosa of ulcerative colitis. Digestion. 2001;63:22-27.
39. Lindsay JO, Feldmann M, Hodgson H, et al. The immunoregulatory role of interleukin-10 in Crohn's disease (CD) cell cultures. Gastroenterology. 2000;118:A110.
40. Rouas-Freiss N, Moreau P, Ferrone S, et al. HLA-G protein in cancer. Do they provide tumor cells with an escape mechanism? Cancer Res. 2005;65:10139-10144.
41. Kallel L, Boubaker J, Louzir H, et al. Colonic expression of gamma-interferon and interleukin-10 in Crohn's disease and ulcerative colitis. Presse Med. 2005;34:8-12.